Quality improvement with biosimilar insulin
22nd September 2020 12.30-13.30
Vicky Ruszala, Specialist Pharmacist in Diabetes and Endocrinology, North Bristol NHS Trust & Su Down, Diabetes Nurse Consultant, Somerset
To understand what biosimilar insulin is and outline the evidence that supports where biosimilars can be used. To consider how biosimilar insulin may impact clinical practice and outline the principles of setting up a quality improvement project in your locality. Cases that have instigated improvements with biosimilar insulin will also be discussed.
This is a promotional webinar series initiated, funded and reviewed by Mylan and may include discussion of its products.